Table:
begin	end	state
1	20	cytoplasmic
21	45	transmembrane
46	56	non-cytoplasmic
57	81	transmembrane
82	90	cytoplasmic
91	111	transmembrane
112	117	non-cytoplasmic
118	145	transmembrane
146	157	cytoplasmic
158	179	transmembrane
180	189	non-cytoplasmic
190	209	transmembrane
210	239	cytoplasmic
240	260	transmembrane
261	269	non-cytoplasmic
270	293	transmembrane
294	304	cytoplasmic
305	327	transmembrane
328	332	non-cytoplasmic
333	351	transmembrane
352	369	cytoplasmic
370	392	transmembrane
393	399	non-cytoplasmic
400	418	transmembrane
419	425	cytoplasmic

Input:
>WP_013088471.1 NCBI__GCF_000092885.1:WP_013088471.1
MNATTAASIAGSRQNSWRAVVAASIGNALEWFDLVVYGFFAVTISKLFFPAGNDTVSLLL
TLGTFGVSFFMRPLGAIVIGAYSDRAGRKAALTLSIMLMMGGTLIIAILPTYQSIGLAAP
LILVLARLMQGFSAGGEFGSATAFLAEHEPGRRGFYASWQMASQGLTTLLAAGFGALLTG
GLSPEQMTSWGWRVPFFFGLLIGPVAFYIRTKLDETPEFLAAETTQTPLRDTFATQKLRL
VIAMGVVILGTVSSYLMLFMPTYGVRQLGLAPSVAFSAIAVTGLIQMVFSPVAGHWSDLH
GRTRIMLGAAVLLFVLVYPAFAFLIAHPSFGTLIVWQIVFGFLVSGYFGATPGLLSEIFP
VQTRTTGMSLAYNIAVTIFGGFGPFIIAWLISVTGSKAAPSYYVMFAALLSIAALIGARR
KLGFR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server